TreeWAS – Variant ID: rs10158481

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.0 Salicylates	0.061	0.939	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.059	0.941	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.058	0.942	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.057	0.943	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.054	0.946	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.054	0.946	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.052	0.948	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.049	0.951	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.049	0.951	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.048	0.952	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.047	0.953	0.000
T36 Poisoning by systemic antibiotics	0.047	0.953	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.046	0.953	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.046	0.954	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.046	0.954	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.046	0.954	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.044	0.956	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.044	0.956	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.044	0.956	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.044	0.956	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.043	0.957	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.042	0.957	0.000
T39.4 Antirheumatics, not elsewhere classified	0.042	0.958	0.000
T39.2 Pyrazolone derivatives	0.042	0.958	0.000
T47.4 Other laxatives	0.042	0.958	0.000
T50.4 Drugs affecting uric acid metabolism	0.042	0.958	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.041	0.958	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.041	0.959	0.000
T50.7 Analeptics and opioid receptor antagonists	0.041	0.959	0.000
T50.5 Appetite depressants	0.041	0.959	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.041	0.959	0.000
T50.1 Loop [high-ceiling] diuretics	0.041	0.959	0.000
T50.0 Mineralocorticoids and their antagonists	0.041	0.959	0.000
T47.6 Antidiarrhoeal drugs	0.041	0.959	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.040	0.960	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.039	0.961	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.039	0.961	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.039	0.961	0.000
T46.7 Peripheral vasodilators	0.039	0.961	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.039	0.961	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.039	0.961	0.000
T50.8 Diagnostic agents	0.038	0.962	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.038	0.962	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.038	0.962	0.000
T47.7 Emetics	0.038	0.962	0.000
T47.5 Digestants	0.038	0.962	0.000
T47.3 Saline and osmotic laxatives	0.038	0.962	0.000
T47.2 Stimulant laxatives	0.038	0.962	0.000
T47.0 Histamine H(2)-receptor antagonists	0.038	0.962	0.000
T36.0 Penicillins	0.038	0.962	0.000
T45.4 Iron and its compounds	0.037	0.962	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.037	0.963	0.000
T38.1 Thyroid hormones and substitutes	0.036	0.964	0.000
T45.0 Antiallergic and antiemetic drugs	0.036	0.964	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.036	0.964	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.036	0.964	0.000
T39.1 4-Aminophenol derivatives	0.036	0.964	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.036	0.964	0.000
T38.9 Other and unspecified hormone antagonists	0.035	0.964	0.000
T38.7 Androgens and anabolic congeners	0.035	0.964	0.000
T38.5 Other oestrogens and progestogens	0.035	0.964	0.000
T38.4 Oral contraceptives	0.035	0.964	0.000
T38.2 Antithyroid drugs	0.035	0.964	0.000
T38.0 Glucocorticoids and synthetic analogues	0.035	0.964	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.036	0.964	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.035	0.965	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.035	0.965	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.035	0.965	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.034	0.966	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.034	0.966	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.034	0.966	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.034	0.966	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.034	0.966	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.034	0.966	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.034	0.966	0.000
T44.0 Anticholinesterase agents	0.034	0.966	0.000
T36.9 Systemic antibiotic, unspecified	0.033	0.966	0.000
T36.8 Other systemic antibiotics	0.033	0.966	0.000
T36.7 Antifungal antibiotics, systemically used	0.033	0.966	0.000
T36.6 Rifamycins	0.033	0.966	0.000
T36.5 Aminoglycosides	0.033	0.966	0.000
T36.4 Tetracyclines	0.033	0.966	0.000
T36.3 Macrolides	0.033	0.966	0.000
T36.2 Chloramphenicol group	0.033	0.966	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.033	0.966	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.033	0.967	0.000
T45.8 Other primarily systemic and haematological agents	0.033	0.967	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.033	0.967	0.000
T45.6 Fibrinolysis-affecting drugs	0.033	0.967	0.000
T45.3 Enzymes, not elsewhere classified	0.033	0.967	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.033	0.967	0.000
T37.5 Antiviral drugs	0.033	0.967	0.000
T37.4 Anthelminthics	0.033	0.967	0.000
T37.3 Other antiprotozoal drugs	0.033	0.967	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.033	0.967	0.000
T37.1 Antimycobacterial drugs	0.033	0.967	0.000
T37.0 Sulphonamides	0.033	0.967	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.033	0.967	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.032	0.967	0.000
T45.2 Vitamins, not elsewhere classified	0.033	0.967	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.031	0.968	0.000
T48.5 Anti-common-cold drugs	0.031	0.968	0.000
T48.4 Expectorants	0.031	0.968	0.000
T48.3 Antitussives	0.031	0.968	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.031	0.968	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.031	0.968	0.000
T48.0 Oxytocic drugs	0.031	0.968	0.000
T49.9 Topical agent, unspecified	0.031	0.968	0.000
T49.8 Other topical agents	0.031	0.968	0.000
T49.7 Dental drugs, topically applied	0.031	0.968	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.031	0.968	0.000
T49.5 Ophthalmological drugs and preparations	0.031	0.968	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.031	0.968	0.000
T49.3 Emollients, demulcents and protectants	0.031	0.968	0.000
T49.2 Local astringents and local detergents	0.031	0.968	0.000
T49.1 Antipruritics	0.031	0.968	0.000
T41.5 Therapeutic gases	0.031	0.969	0.000
T41.4 Anaesthetic, unspecified	0.031	0.969	0.000
T41.3 Local anaesthetics	0.031	0.969	0.000
T41.2 Other and unspecified general anaesthetics	0.031	0.969	0.000
T41.1 Intravenous anaesthetics	0.031	0.969	0.000
T41.0 Inhaled anaesthetics	0.031	0.969	0.000
T51.0 Ethanol	0.030	0.970	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.030	0.970	0.000
T45.5 Anticoagulants	0.029	0.971	0.000
T42.3 Barbiturates	0.028	0.972	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.028	0.972	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.028	0.972	0.000
T46.1 Calcium-channel blockers	0.026	0.973	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.027	0.973	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.026	0.974	0.000
T43.9 Psychotropic drug, unspecified	0.026	0.974	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.026	0.974	0.000
T42.1 Iminostilbenes	0.026	0.974	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.026	0.974	0.000
T42.2 Succinimides and oxazolidinediones	0.026	0.974	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.025	0.975	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.024	0.976	0.000
T51 Toxic effect of alcohol	0.023	0.977	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.020	0.980	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.020	0.980	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.019	0.981	0.000
T40.8 Lysergide [LSD]	0.019	0.981	0.000
T40.7 Cannabis (derivatives)	0.019	0.981	0.000
T40.5 Cocaine	0.019	0.981	0.000
T40.3 Methadone	0.019	0.981	0.000
T40.1 Heroin	0.019	0.981	0.000
T40.0 Opium	0.019	0.981	0.000
T43.6 Psychostimulants with abuse potential	0.019	0.981	0.000
T42.0 Hydantoin derivatives	0.017	0.982	0.000
T40.4 Other synthetic narcotics	0.017	0.983	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.017	0.983	0.000
T51.8 Other alcohols	0.016	0.983	0.000
T51.3 Fusel oil	0.016	0.983	0.000
T51.2 2-Propanol	0.016	0.983	0.000
T51.1 Methanol	0.016	0.983	0.000
T51.9 Alcohol, unspecified	0.016	0.984	0.000
T40.2 Other opioids	0.016	0.984	0.000
Z43.2 Attention to ileostomy	0.016	0.984	0.000
T63 Toxic effect of contact with venomous animals	0.015	0.985	0.000
T65 Toxic effect of other and unspecified substances	0.015	0.985	0.000
T56 Toxic effect of metals	0.015	0.985	0.000
T63.4 Venom of other arthropods	0.014	0.986	0.000
T65.9 Toxic effect of unspecified substance	0.014	0.986	0.000
Z03.9 Observation for suspected disease or condition, unspecified	0.000	0.986	0.014
O36.0 Maternal care for rhesus isoimmunisation	0.014	0.986	0.000
C25.9 Pancreas, unspecified	0.013	0.987	0.000
T58 Toxic effect of carbon monoxide	0.013	0.987	0.000
T40.6 Other and unspecified narcotics	0.013	0.987	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.013	0.987	0.000
T56.8 Other metals	0.013	0.987	0.000
C25 Malignant neoplasm of pancreas	0.013	0.987	0.000
T62 Toxic effect of other noxious substances eaten as food	0.013	0.987	0.000
T61 Toxic effect of noxious substances eaten as seafood	0.013	0.987	0.000
T60 Toxic effect of pesticides	0.013	0.987	0.000
T57 Toxic effect of other inorganic substances	0.013	0.987	0.000
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.013	0.987	0.000
T52 Toxic effect of organic solvents	0.013	0.987	0.000
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.013	0.987	0.000
T55 Toxic effect of soaps and detergents	0.013	0.987	0.000
T54 Toxic effect of corrosive substances	0.012	0.988	0.000
C25.1 Body of pancreas	0.012	0.988	0.000
G82 Paraplegia and tetraplegia	0.012	0.988	0.000
G82.1 Spastic paraplegia	0.012	0.988	0.000
G82.5 Tetraplegia, unspecified	0.012	0.988	0.000
G82.4 Spastic tetraplegia	0.011	0.989	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.011	0.989	0.000
T63.8 Toxic effect of contact with other venomous animals	0.011	0.989	0.000
T63.6 Toxic effect of contact with other marine animals	0.011	0.989	0.000
T63.5 Toxic effect of contact with fish	0.011	0.989	0.000
T63.3 Venom of spider	0.011	0.989	0.000
T63.2 Venom of scorpion	0.011	0.989	0.000
T63.1 Venom of other reptiles	0.011	0.989	0.000
T63.0 Snake venom	0.011	0.989	0.000
T65.8 Toxic effect of other specified substances	0.011	0.989	0.000
T65.6 Paints and dyes, not elsewhere classified	0.011	0.989	0.000
T65.5 Nitroglycerin and other nitric acids and esters	0.011	0.989	0.000
T65.4 Carbon disulphide	0.011	0.989	0.000
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.011	0.989	0.000
T65.2 Tobacco and nicotine	0.011	0.989	0.000
T65.1 Strychnine and its salts	0.011	0.989	0.000
T65.0 Cyanides	0.011	0.989	0.000
C25.0 Head of pancreas	0.011	0.989	0.000
E11.5 With peripheral circulatory complications	0.000	0.989	0.011
C25.7 Other parts of pancreas	0.011	0.989	0.000
T56.9 Metal, unspecified	0.011	0.989	0.000
T56.7 Beryllium and its compounds	0.011	0.989	0.000
T56.6 Tin and its compounds	0.011	0.989	0.000
T56.5 Zinc and its compounds	0.011	0.989	0.000
T56.4 Copper and its compounds	0.011	0.989	0.000
T56.3 Cadmium and its compounds	0.011	0.989	0.000
T56.2 Chromium and its compounds	0.011	0.989	0.000
T56.1 Mercury and its compounds	0.011	0.989	0.000
T56.0 Lead and its compounds	0.011	0.989	0.000
L97 Ulcer of lower limb, not elsewhere classified	0.000	0.989	0.011
C25.4 Endocrine pancreas	0.011	0.989	0.000
T42.4 Benzodiazepines	0.010	0.990	0.000
C25.3 Pancreatic duct	0.010	0.990	0.000
T59 Toxic effect of other gases, fumes and vapours	0.010	0.990	0.000
K59.1 Functional diarrhoea	0.000	0.991	0.009
C25.8 Overlapping lesion of pancreas	0.009	0.991	0.000
T52.9 Organic solvent, unspecified	0.009	0.991	0.000
T52.8 Other organic solvents	0.009	0.991	0.000
T52.4 Ketones	0.009	0.991	0.000
T52.3 Glycols	0.009	0.991	0.000
T52.2 Homologues of benzene	0.009	0.991	0.000
T52.1 Benzene	0.009	0.991	0.000
T52.0 Petroleum products	0.009	0.991	0.000
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.009	0.991	0.000
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.009	0.991	0.000
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.009	0.991	0.000
T53.5 Chlorofluorocarbons	0.009	0.991	0.000
T53.4 Dichloromethane	0.009	0.991	0.000
T53.3 Tetrachloroethylene	0.009	0.991	0.000
T53.2 Trichloroethylene	0.009	0.991	0.000
T53.1 Chloroform	0.009	0.991	0.000
T53.0 Carbon tetrachloride	0.009	0.991	0.000
T57.9 Inorganic substance, unspecified	0.009	0.991	0.000
T57.8 Other specified inorganic substances	0.009	0.991	0.000
T57.3 Hydrogen cyanide	0.009	0.991	0.000
T57.2 Manganese and its compounds	0.009	0.991	0.000
T57.1 Phosphorus and its compounds	0.009	0.991	0.000
T57.0 Arsenic and its compounds	0.009	0.991	0.000
T60.9 Pesticide, unspecified	0.009	0.991	0.000
T60.8 Other pesticides	0.009	0.991	0.000
T60.4 Rodenticides	0.009	0.991	0.000
T60.3 Herbicides and fungicides	0.009	0.991	0.000
T60.2 Other insecticides	0.009	0.991	0.000
T60.1 Halogenated insecticides	0.009	0.991	0.000
T60.0 Organophosphate and carbamate insecticides	0.009	0.991	0.000
T61.9 Toxic effect of unspecified seafood	0.009	0.991	0.000
T61.8 Toxic effect of other seafoods	0.009	0.991	0.000
T61.2 Other fish and shellfish poisoning	0.009	0.991	0.000
T61.1 Scombroid fish poisoning	0.009	0.991	0.000
T61.0 Ciguatera fish poisoning	0.009	0.991	0.000
T62.9 Noxious substance eaten as food, unspecified	0.009	0.991	0.000
T62.8 Other specified noxious substances eaten as food	0.009	0.991	0.000
T62.2 Other ingested (parts of) plant(s)	0.009	0.991	0.000
T62.1 Ingested berries	0.009	0.991	0.000
T62.0 Ingested mushrooms	0.009	0.991	0.000
C25.2 Tail of pancreas	0.009	0.991	0.000
G82.2 Paraplegia, unspecified	0.009	0.991	0.000
T54.3 Corrosive alkalis and alklali-like substances	0.009	0.991	0.000
T54.2 Corrosive acids and acid-like substances	0.009	0.991	0.000
T54.1 Other corrosive organic compounds	0.009	0.991	0.000
T54.0 Phenol and phenol homologues	0.009	0.991	0.000
G82.3 Flaccid tetraplegia	0.009	0.991	0.000
G82.0 Flaccid paraplegia	0.009	0.991	0.000
E11 Non-insulin-dependent diabetes mellitus	0.000	0.992	0.008
T54.9 Corrosive substance, unspecified	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
E11.0 With coma	0.000	0.992	0.008
O14.9 Preeclampsia, unspecified	0.008	0.992	0.000
E11.1 With ketoacidosis	0.000	0.992	0.008
E10 Insulin-dependent diabetes mellitus	0.000	0.993	0.007
E10.2 With renal complications	0.000	0.993	0.007
T59.9 Gases, fumes and vapours, unspecified	0.007	0.993	0.000
T59.7 Carbon dioxide	0.007	0.993	0.000
T59.6 Hydrogen sulphide	0.007	0.993	0.000
T59.5 Fluorine gas and hydrogen fluoride	0.007	0.993	0.000
T59.4 Chlorine gas	0.007	0.993	0.000
T59.3 Lachrymogenic gas	0.007	0.993	0.000
T59.2 Formaldehyde	0.007	0.993	0.000
T59.1 Sulphur dioxide	0.007	0.993	0.000
T59.0 Nitrogen oxides	0.007	0.993	0.000
E10.3 With ophthalmic complications	0.000	0.993	0.007
N32.3 Diverticulum of bladder	0.000	0.993	0.007
E11.6 With other specified complications	0.000	0.993	0.007
E11.2 With renal complications	0.000	0.993	0.007
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.993	0.007
Z43.3 Attention to colostomy	0.007	0.993	0.000
E10.5 With peripheral circulatory complications	0.000	0.993	0.007
E10.4 With neurological complications	0.000	0.993	0.007
G93.3 Postviral fatigue syndrome	0.000	0.993	0.007
O14.0 Moderate preeclampsia	0.006	0.994	0.000
E10.1 With ketoacidosis	0.000	0.994	0.006
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.006	0.994	0.000
E11.7 With multiple complications	0.000	0.994	0.006
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.994	0.006
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.994	0.006
M86.9 Osteomyelitis, unspecified	0.000	0.994	0.006
E10-E14 Diabetes mellitus	0.000	0.994	0.006
E10.8 With unspecified complications	0.000	0.994	0.006
E10.7 With multiple complications	0.000	0.994	0.006
E10.0 With coma	0.000	0.994	0.006
M22.8 Other disorders of patella	0.000	0.994	0.006
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.005	0.995	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.995	0.005
Z43 Attention to artificial openings	0.004	0.995	0.001
E10.6 With other specified complications	0.000	0.995	0.005
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.000	0.995	0.005
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.000	0.995	0.005
G80-G83 Cerebral palsy and other paralytic syndromes	0.005	0.995	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.000	0.995	0.005
E11.3 With ophthalmic complications	0.000	0.995	0.005
H65 Nonsuppurative otitis media	0.005	0.995	0.000
O14.2 HELLP syndrome	0.005	0.995	0.000
M65.34 Trigger finger-Hand	0.005	0.995	0.000
O14.1 Severe preeclampsia	0.005	0.995	0.000
E11.4 With neurological complications	0.000	0.995	0.005
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.005	0.995	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.005	0.995	0.000
G80 Infantile cerebral palsy	0.004	0.995	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.000	0.996	0.004
M86.92 Osteomyelitis, unspecified (Upper arm)	0.000	0.996	0.004
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.000	0.996	0.004
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.000	0.996	0.004
E12 Malnutrition-related diabetes mellitus	0.000	0.996	0.004
E11.8 With unspecified complications	0.000	0.996	0.004
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.996	0.004
T59.8 Other specified gases, fumes and vapours	0.004	0.996	0.001
M86.96 Osteomyelitis, unspecified (Lower leg)	0.000	0.996	0.004
Z01.8 Other specified special examinations	0.004	0.996	0.000
M86.94 Osteomyelitis, unspecified (Hand)	0.000	0.996	0.004
Z43.9 Attention to unspecified artificial opening	0.003	0.996	0.001
Z43.7 Attention to artificial vagina	0.003	0.996	0.001
G83 Other paralytic syndromes	0.004	0.996	0.000
Z43.8 Attention to other artificial openings	0.003	0.996	0.001
H65.0 Acute serous otitis media	0.004	0.996	0.000
H65.1 Other acute nonsuppurative otitis media	0.004	0.996	0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.004	0.996	0.000
G80.8 Other infantile cerebral palsy	0.004	0.996	0.000
M65.3 Trigger finger	0.004	0.996	0.000
G80.2 Infantile hemiplegia	0.004	0.996	0.000
M65.9 Synovitis and tenosynovitis, unspecified	0.004	0.996	0.000
Z43.5 Attention to cyctostomy	0.003	0.996	0.001
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.000	0.996	0.004
H65.2 Chronic serous otitis media	0.004	0.996	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.004	0.996	0.000
S82.40 Fracture of fibula alone (closed)	0.000	0.996	0.004
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)	0.004	0.996	0.000
G80.1 Spastic diplegia	0.003	0.996	0.000
G83.9 Paralytic syndrome, unspecified	0.004	0.996	0.000
K59.3 Megacolon, not elsewhere classified	0.000	0.996	0.004
M11.2 Other chondrocalcinosis	0.000	0.996	0.004
H65.4 Other chronic nonsuppurative otitis media	0.004	0.996	0.000
G83.4 Cauda equina syndrome	0.004	0.996	0.000
G80.4 Ataxic cerebral palsy	0.003	0.996	0.000
G80.3 Dyskinetic cerebral palsy	0.003	0.996	0.000
E12.9 Without complications	0.000	0.997	0.003
E12.8 With unspecified complications	0.000	0.997	0.003
E12.7 With multiple complications	0.000	0.997	0.003
E12.6 With other specified complications	0.000	0.997	0.003
E12.5 With peripheral circulatory complications	0.000	0.997	0.003
E12.4 With neurological complications	0.000	0.997	0.003
E12.3 With ophthalmic complications	0.000	0.997	0.003
E12.2 With renal complications	0.000	0.997	0.003
E12.1 With ketoacidosis	0.000	0.997	0.003
E12.0 With coma	0.000	0.997	0.003
M22 Disorders of patella	0.000	0.997	0.003
G80.0 Spastic cerebral palsy	0.003	0.997	0.000
Z43.0 Attention to tracheostomy	0.002	0.997	0.001
E13 Other specified diabetes mellitus	0.000	0.997	0.003
M65 Synovitis and tenosynovitis	0.003	0.997	0.000
G80.9 Infantile cerebral palsy, unspecified	0.003	0.997	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.003	0.997	0.000
G83.5 Locked-in syndrome	0.003	0.997	0.000
G83.3 Monoplegia, unspecified	0.003	0.997	0.000
G83.0 Diplegia of upper limbs	0.003	0.997	0.000
M22.3 Other derangements of patella	0.000	0.997	0.003
F43.0 Acute stress reaction	0.003	0.997	0.000
G83.8 Other specified paralytic syndromes	0.003	0.997	0.000
F43.2 Adjustment disorders	0.003	0.997	0.000
G83.2 Monoplegia of upper limb	0.003	0.997	0.000
K59.9 Functional intestinal disorder, unspecified	0.000	0.997	0.003
W19.4 Street and highway	0.000	0.997	0.003
K59 Other functional intestinal disorders	0.000	0.997	0.003
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.002	0.997	0.001
M65.39 Trigger finger-Site unspec	0.003	0.997	0.000
M65.38 Trigger finger-Other	0.003	0.997	0.000
M65.37 Trigger finger-Ankle/foot	0.003	0.997	0.000
M65.36 Trigger finger-Lower leg	0.003	0.997	0.000
M65.35 Trigger finger-Pelvic/thigh	0.003	0.997	0.000
M65.33 Trigger finger-Forearm	0.003	0.997	0.000
M65.32 Trigger finger-Upper arm	0.003	0.997	0.000
M65.31 Trigger finger-Shldr region	0.003	0.997	0.000
M65.30 Trigger finger-Mult sites	0.003	0.997	0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)	0.003	0.997	0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)	0.003	0.997	0.000
Z01.7 Laboratory examination	0.003	0.997	0.000
M65.8 Other synovitis and tenosynovitis	0.003	0.997	0.000
M86 Osteomyelitis	0.000	0.997	0.003
T93.2 Sequelae of other fractures of lower limb	0.000	0.997	0.003
S92.10 Fracture of talus (closed)	0.003	0.997	0.000
S99.9 Unspecified injury of ankle and foot	0.003	0.997	0.000
M11.29 Other chondrocalcinosis (Site unspecified)	0.000	0.997	0.003
M11.28 Other chondrocalcinosis (Other)	0.000	0.997	0.003
M11.27 Other chondrocalcinosis (Ankle and foot)	0.000	0.997	0.003
M11.25 Other chondrocalcinosis (Pelvic region and thigh)	0.000	0.997	0.003
M11.24 Other chondrocalcinosis (Hand)	0.000	0.997	0.003
M11.23 Other chondrocalcinosis (Forearm)	0.000	0.997	0.003
M11.22 Other chondrocalcinosis (Upper arm)	0.000	0.997	0.003
M11.21 Other chondrocalcinosis (Shoulder region)	0.000	0.997	0.003
M11.20 Other chondrocalcinosis (Multiple sites)	0.000	0.997	0.003
M65.86 Other synovitis and tenosynovitis (Lower leg)	0.003	0.997	0.000
M65.84 Other synovitis and tenosynovitis (Hand)	0.003	0.997	0.000
M22.0 Recurrent dislocation of patella	0.000	0.997	0.003
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
S92.1 Fracture of talus	0.003	0.997	0.000
S92 Fracture of foot, except ankle	0.003	0.997	0.000
S92.70 Multiple fractures of foot (closed)	0.003	0.997	0.000
M22.2 Patellofemoral disorders	0.000	0.997	0.003
S92.7 Multiple fractures of foot	0.003	0.997	0.000
M22.1 Recurrent subluxation of patella	0.000	0.997	0.003
M22.9 Disorder of patella, unspecified	0.000	0.997	0.003
S92.4 Fracture of great toe	0.003	0.997	0.000
T93 Sequelae of injuries of lower limb	0.000	0.997	0.003
S02.30 Fracture of orbital floor (closed)	0.003	0.997	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.003	0.997	0.000
E13.8 With unspecified complications	0.000	0.997	0.002
E13.7 With multiple complications	0.000	0.997	0.002
E13.6 With other specified complications	0.000	0.997	0.002
E13.5 With peripheral circulatory complications	0.000	0.997	0.002
E13.4 With neurological complications	0.000	0.997	0.002
E13.3 With ophthalmic complications	0.000	0.997	0.002
E13.2 With renal complications	0.000	0.997	0.002
E13.1 With ketoacidosis	0.000	0.997	0.002
E13.0 With coma	0.000	0.997	0.002
M14.6 Neuropathic arthropathy	0.000	0.997	0.003
M65.2 Calcific tendinitis	0.003	0.997	0.000
M65.1 Other infective (teno)synovitis	0.003	0.997	0.000
M65.0 Abscess of tendon sheath	0.003	0.997	0.000
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis	0.003	0.997	0.000
M65.81 Other synovitis and tenosynovitis (Shoulder region)	0.003	0.997	0.000
S92.40 Fracture of great toe (closed)	0.003	0.997	0.000
M86.8 Other osteomyelitis	0.000	0.997	0.002
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.003	0.997	0.000
M22.4 Chondromalacia patellae	0.000	0.997	0.003
M23.34 Other meniscus derangements (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.003	0.997	0.000
H11.1 Conjunctival degenerations and deposits	0.003	0.997	0.000
S99 Other and unspecified injuries of ankle and foot	0.002	0.997	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.997	0.003
S91.2 Open wound of toe(s) with damage to nail	0.002	0.997	0.000
F43.1 Posttraumatic stress disorder	0.002	0.997	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.000	0.997	0.002
B23.8 HIV disease resulting in other specified conditions	0.002	0.998	0.000
O26.2 Pregnancy care of habitual aborter	0.002	0.998	0.000
Z01.9 Special examination, unspecified	0.002	0.998	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.000	0.998	0.002
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.998	0.002
M65.89 Other synovitis and tenosynovitis (Site unspecified)	0.002	0.998	0.000
M65.88 Other synovitis and tenosynovitis (Other)	0.002	0.998	0.000
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)	0.002	0.998	0.000
M65.82 Other synovitis and tenosynovitis (Upper arm)	0.002	0.998	0.000
M65.80 Other synovitis and tenosynovitis (Multiple sites)	0.002	0.998	0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)	0.002	0.998	0.000
G83.1 Monoplegia of lower limb	0.002	0.998	0.000
S92.3 Fracture of metatarsal bone	0.002	0.998	0.000
Z01.1 Examination of ears and hearing	0.002	0.998	0.000
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.002	0.998	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.000	0.998	0.002
M86.4 Chronic osteomyelitis with draining sinus	0.000	0.998	0.002
M86.3 Chronic multifocal osteomyelitis	0.000	0.998	0.002
M86.2 Subacute osteomyelitis	0.000	0.998	0.002
M86.0 Acute haematogenous osteomyelitis	0.000	0.998	0.002
S91 Open wound of ankle and foot	0.002	0.998	0.000
Z43.1 Attention to gastrostomy	0.001	0.998	0.002
G11.9 Hereditary ataxia, unspecified	0.002	0.998	0.000
H11 Other disorders of conjunctiva	0.002	0.998	0.000
K59.2 Neurogenic bowel, not elsewhere classified	0.000	0.998	0.002
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.002	0.998	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.998	0.002
S93.3 Dislocation of other and unspecified parts of foot	0.002	0.998	0.000
M86.1 Other acute osteomyelitis	0.000	0.998	0.002
Z01.4 Gynaecological examination (general)(routine)	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.000	0.998	0.002
S90-S99 Injuries to the ankle and foot	0.002	0.998	0.000
F43.9 Reaction to severe stress, unspecified	0.002	0.998	0.000
F43.8 Other reactions to severe stress	0.002	0.998	0.000
O26 Maternal care for other conditions predominantly related to pregnancy	0.002	0.998	0.000
S00.0 Superficial injury of scalp	0.000	0.998	0.002
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.998	0.002
S92.11 Fracture of talus (open)	0.002	0.998	0.000
H11.2 Conjunctival scars	0.002	0.998	0.000
S92.9 Fracture of foot, unspecified	0.002	0.998	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.002	0.998	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.002	0.998	0.000
S91.1 Open wound of toe(s) without damage to nail	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations